The electrophysiologic behavior of the heart is highly heterogeneous. It has been, and continues to be, the goal of this Program to define mechanisms underlying this heterogeneity. In the last period of support, substantial progress has been made toward this goal. The present renewal application has been restructured to focus specifically on cardiac potassium channels, testing the overall working hypothesis that variability in expression or function of these channels is an important determinant of heterogenous repolarization both in health and in disease. The studies proposed will incorporate both conventional molecular and electrophysiologic techniques as well as new techniques in which Program investigators and collaborators have developed considerable expertise in the last period of support; these include generation of genetically-modified mice, in situ hybridization, the molecular genetics of cardiac ion channels, and spin labeling/EPR technology. In each Project, preliminary data that attest to feasibility are presented, and specific hypotheses relating to the mechanisms underlying heterogeneous function or expression of cardiac K plus channels are proposed for testing. The experimental models include wild-type and mutant channels in heterologous expression systems, the use of genetically-modified animals, and studies in human subjects. The focus of the central theme of cardiac potassium channels allows a high degree of scientific interchange among Projects; this includes the use of shared reagents, as well as the likelihood that results in one Project influence the scientific direction in others. Dysfunction of cardiac potassium channels is increasingly recognized to play a role in the genesis of cardiac arrhythmias. The studies proposed in this Program will help elucidate mechanisms underlying this dysfunction, and therefore point to novel approaches to therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL046681-08
Application #
6043770
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
1992-08-01
Project End
2002-07-31
Budget Start
1999-09-15
Budget End
2000-07-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Yang, Tao; Smith, Jarrod A; Leake, Brenda F et al. (2013) An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1. Mol Pharmacol 83:481-9
Hayashi, Kenshi; Shuai, Wen; Sakamoto, Yuichiro et al. (2010) Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Heart Rhythm 7:973-80
Yang, Tao; McBride, Brian F; Leake, Brenda F et al. (2010) Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. Br J Pharmacol 161:1023-33
Stepanovic, Svetlana Z; Potet, Franck; Petersen, Christina I et al. (2009) The evolutionarily conserved residue A653 plays a key role in HERG channel closing. J Physiol 587:2555-66
Yang, Tao; Chung, Seo-Kyung; Zhang, Wei et al. (2009) Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome. Circ Arrhythm Electrophysiol 2:417-26
Potet, Franck; Petersen, Christina I; Boutaud, Olivier et al. (2009) Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator. J Mol Cell Cardiol 46:257-67
Yang, Tao; Kanki, Hideaki; Zhang, Wei et al. (2009) Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylation. Br J Pharmacol 157:952-61
Grueter, Chad E; Abiria, Sunday A; Wu, Yunji et al. (2008) Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits. Biochemistry 47:1760-7
Baudenbacher, Franz; Schober, Tilmann; Pinto, Jose Renato et al. (2008) Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893-903
Makita, Naomasa; Behr, Elijah; Shimizu, Wataru et al. (2008) The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 118:2219-29

Showing the most recent 10 out of 171 publications